Tue, April 23, 2013
[ Tue, Apr 23rd 2013 ] - Market Wire
AMRI and Ono Broaden SMARTSOURCINGa" Collaboration
[ Tue, Apr 23rd 2013 ] - Market Wire
Celsion Corporation Provides Business Update
[ Tue, Apr 23rd 2013 ] - Market Wire
ISIS Pharmaceuticals Initiates a Clinical Study o .. IS-SMN Rx in Infants With Spinal Muscular Atrophy
[ Tue, Apr 23rd 2013 ] - Market Wire
Summit NW Selects Implant Sciences' QS-B220 Trace Detection System for Air Cargo Screening
[ Tue, Apr 23rd 2013 ] - Market Wire
Poorest U.S. States Rank Among Most Wasteful in Unnecessary Medication-Related Costs
[ Tue, Apr 23rd 2013 ] - Market Wire
New Data from AbbVie's Phase IIb Aviator Trial De .. l Response Rates Across Multiple Patient Types wi
[ Tue, Apr 23rd 2013 ] - Market Wire
Alchemia Announces Multi-Target Drug Discovery Co .. ation With AstraZeneca on VAST Discovery Platform
[ Tue, Apr 23rd 2013 ] - Market Wire
Ion Protona" de Life Technologies impulsa Stratified Medicine Scotland Innovation Centre
[ Tue, Apr 23rd 2013 ] - Market Wire
Ion Protona" da Life Technologies vai sustentar o Stratified Medicine Scotland Innovation Centre
[ Tue, Apr 23rd 2013 ] - Market Wire
Life Technologies' Ion Protona" to Power Stratified Medicine Scotland Innovation Centre
Mon, April 22, 2013
[ Mon, Apr 22nd 2013 ] - Market Wire
Galapagos starts Phase 2A study with GLPG0974 in ulcerative colitis
[ Mon, Apr 22nd 2013 ] - Market Wire
Lifshitz Law Firm Announces Investigation of Anar .. Life Technologies Corporation and National Finan
[ Mon, Apr 22nd 2013 ] - Market Wire
MiMedx Group, Inc. Announces Listing on the NASDAQ Capital Market
[ Mon, Apr 22nd 2013 ] - Market Wire
IMRIS to exhibit novel state-of-the-art VISIUS iCT imaging solution at AANS
[ Mon, Apr 22nd 2013 ] - Market Wire
Mylan Announces $1 Million Gift to The Pittsburgh Promise Scholarship Fund
[ Mon, Apr 22nd 2013 ] - Market Wire
Cheaper Gas, Airfare, Profits on Way as Commoditi .. s? - Top Small Cap Stock Focus Ahead of the Bell:
[ Mon, Apr 22nd 2013 ] - Market Wire
VentriPoint Announces Closing of Offering
[ Mon, Apr 22nd 2013 ] - Market Wire
Implant Sciences' Quantum Sniffer Explosives and .. to Be Exhibited at 11th Annual Expo Seguridad Me
[ Mon, Apr 22nd 2013 ] - Market Wire
Novadaq to Release First Quarter 2013 Financial R .. sults On April 29, 2013-Conference Call to Follow
[ Mon, Apr 22nd 2013 ] - Market Wire
GSK and Theravance Announce Regulatory Submission for ANORO(TM) ELLIPTA(TM) (UMEC/VI) in Japan
Sun, April 21, 2013
[ Sun, Apr 21st 2013 ] - Market Wire
Galapagos discovers novel candidate drug to treat breast cancer
Fri, April 19, 2013
[ Fri, Apr 19th 2013 ] - Market Wire
Red Oak Partners Issues Open Letter to Digirad Co .. tion Shareholders About the Current Proxy Contest
[ Fri, Apr 19th 2013 ] - Market Wire
Ceregene Reports Data From Parkinson's Disease Phase 2b Study
[ Fri, Apr 19th 2013 ] - Market Wire
Novo Nordisk Unveils New U.S. Headquarters
[ Fri, Apr 19th 2013 ] - Market Wire
CML HealthCare Inc.'s Subsidiary, Hemostasis Refe .. rded Contract Extension with Isis Pharmaceuticals
[ Fri, Apr 19th 2013 ] - Market Wire
Ceapro Reports Full-Year 2012 Financial and Operating Results
[ Fri, Apr 19th 2013 ] - Market Wire
BioScrip Prices Underwritten Offering of Common Stock
[ Fri, Apr 19th 2013 ] - Market Wire
iTech Medical, Inc. Enters Into Letter of Intent .. tal Ventures Inc. in Respect of a Proposed Merger
[ Fri, Apr 19th 2013 ] - Market Wire
Varian Medical Systems and Paul Scherrer Institut .. ounce Collaboration on Motion Management for IMPT
[ Fri, Apr 19th 2013 ] - Market Wire
Interim PILLAR II Results Reported During SAGES
[ Fri, Apr 19th 2013 ] - Market Wire
Omeros to Present Additional OMS302 Clinical Data .. the Annual ASCRS and ASOA Symposium and Congress
Thu, April 18, 2013
[ Thu, Apr 18th 2013 ] - Market Wire
La Jolla Pharmaceutical Company Receives Orphan Designation From FDA for LJPC-6417
[ Thu, Apr 18th 2013 ] - Market Wire
NW Bio Announces $10 Million Registered Direct Offering
[ Thu, Apr 18th 2013 ] - Market Wire
NW Bio Announces That Another Brain Cancer Patien .. rials Has Surpassed Ten-Year Cancer-Free Survival
[ Thu, Apr 18th 2013 ] - Market Wire
Unilife Develops Unifill Assurea" to Enhance Patient Self-Injection of Biologics
[ Thu, Apr 18th 2013 ] - Market Wire
UMeWorld New Trading Symbol "UMEWF" to Be Effective From April 18, 2013
[ Thu, Apr 18th 2013 ] - Market Wire
BD Anuncia Aprovao FDA 510(k) e Lanamento Comercial do BD UltraSafe PLUSa" Passive Needle Guard
[ Thu, Apr 18th 2013 ] - Market Wire
Accuray Provides Clarification on Recently Initiated Voluntary Recalls
[ Thu, Apr 18th 2013 ] - Market Wire
Implant Sciences Showcases Its Explosive Trace De .. ection Equipment at Counter Terror Expo in London
[ Thu, Apr 18th 2013 ] - Market Wire
United Therapeutics Corporation To Announce First .. ts Before Market Open On Thursday, April 25, 2013
[ Thu, Apr 18th 2013 ] - Market Wire
Un estudio publicado en European Radiology apoya el uso de la tomosntesis de mama de Hologic
Wed, April 17, 2013
[ Wed, Apr 17th 2013 ] - Market Wire
Cantel Medical To Present At Needham 12th Annual Healthcare Conference
[ Wed, Apr 17th 2013 ] - Market Wire
Arena Pharma, Celgene, Incyte, Spectrum Pharma, and Geron Under StockCall's Microscope
[ Wed, Apr 17th 2013 ] - Market Wire
Syneron Medical Appoints Co-Founder and Chairman .. Board Shimon Eckhouse to Chief Executive Officer
[ Wed, Apr 17th 2013 ] - Market Wire
Stem Cell Therapeutics Licenses Exclusive Rights to Clinical Cancer Stem Cell Program
[ Wed, Apr 17th 2013 ] - Market Wire
VentriPoint Receives CE Mark for Major Expansion of Its VMST Platform for Right Heart Analysis
[ Wed, Apr 17th 2013 ] - Market Wire
Lorus Therapeutics Signs Research and License Option Agreement with Elanco
[ Wed, Apr 17th 2013 ] - Market Wire
Quest Diagnostics to Acquire Lab-Related Clinical .. ations of Dignity Health in California and Nevada
[ Wed, Apr 17th 2013 ] - Market Wire
CML HealthCare Inc. Appoints Chief Medical Officer
[ Wed, Apr 17th 2013 ] - Market Wire
Almirall und Forest Laboratories geben positive R .. zur Kombination von Aclidinium und Formoterol be
[ Wed, Apr 17th 2013 ] - Market Wire
Almirall e Forest Laboratories annunciano i risul .. i fase III per la combinazione aclidinium e formo
Tue, April 16, 2013
[ Tue, Apr 16th 2013 ] - Market Wire
BioScrip Announces Proposed Refinancing of Existing Indebtedness
[ Tue, Apr 16th 2013 ] - Market Wire
BioScrip Announces Proposed Public Offering of Common Stock
[ Tue, Apr 16th 2013 ] - Market Wire
Oramed Pharmaceuticals Appoints New Chief Operating Officer and VP of Business Development
[ Tue, Apr 16th 2013 ] - Market Wire
Critical Outcome Technologies Inc. Strengthens Investor Communications
[ Tue, Apr 16th 2013 ] - Market Wire
Cynosure To Host First-Quarter 2013 Financial Results Conference Call On April 30
[ Tue, Apr 16th 2013 ] - Market Wire
NW Bio's Phase III Trial With DCVax-L For Brain C .. dquot;; As A National Priority Trial In UK
[ Tue, Apr 16th 2013 ] - Market Wire
Lilly Announces Positive Results of Phase III Trials of Dulaglutide in Type 2 Diabetes
[ Tue, Apr 16th 2013 ] - Market Wire
Immunovaccine Receives Financial Contribution fro .. Provide Support Towards Clinical Studies in Comm
[ Tue, Apr 16th 2013 ] - Market Wire
Sequenom CMM Achieves Milestone Of 100,000 MaterniT21a" Plus Tests Processed
[ Tue, Apr 16th 2013 ] - Market Wire
DURECT Announces Submission of New Drug Application for POSIDURa" (SABER-Bupivacaine)
Mon, April 15, 2013
[ Mon, Apr 15th 2013 ] - Market Wire
Hospira Names Matthew R. Stober Senior Vice President of Operations
[ Mon, Apr 15th 2013 ] - Market Wire
Star Scientific's Anatabloc Brand Ambassadors, Fr .. ples and John Isner, Shine at Weekend Tournaments
[ Mon, Apr 15th 2013 ] - Market Wire
Bernstein Liebhard LLP Announces Investigation Of Acquisition By Thermo Fisher Scientific
[ Mon, Apr 15th 2013 ] - Market Wire
IsoRay on Display at the American Brachytherapy S .. eaturing Its Cesium-131 Cancer Fighting Portfolio
[ Mon, Apr 15th 2013 ] - Market Wire
Vycor Launches New Extension Arm for Its Patented ViewSite(TM) Brain Access System (VBAS)
[ Mon, Apr 15th 2013 ] - Market Wire
Med BioGene Announces Date of Annual and Special Meeting
[ Mon, Apr 15th 2013 ] - Market Wire
SeeThruEquity Initiates Coverage on Milestone Scientific
[ Mon, Apr 15th 2013 ] - Market Wire
AlphaRx Announces Name Change to UMeWorld Limited .. 's Focus, Direction and Commitment to Create Sign
[ Mon, Apr 15th 2013 ] - Market Wire
Royalty Pharma Announces Firm Offer to Acquire Elan
[ Mon, Apr 15th 2013 ] - Market Wire
Abbott Initiates Voluntary Recall of FreeStyle InsuLinx Blood Glucose Meters in the United States
Fri, April 12, 2013
[ Fri, Apr 12th 2013 ] - Market Wire
Quick-Med Engages Match Point Partners as Financial Advisor
[ Fri, Apr 12th 2013 ] - Market Wire
Gestion notify of 4.97% shareholding in Galapagos
[ Fri, Apr 12th 2013 ] - Market Wire
Boston Scientific Launches Precision Spectraa" Spinal Cord Stimulator System In The United States
[ Fri, Apr 12th 2013 ] - Market Wire
Life Technologies Acquires KDR Biotech Co., LTD., Leading Reagents Distributor
[ Fri, Apr 12th 2013 ] - Market Wire
Pre-Market Analysis on Life Technologies, Quest D .. Senior Living, Antares Pharma, and Optimer Pharma
[ Fri, Apr 12th 2013 ] - Market Wire
HCA Holdings, Tenet Healthcare, Health Management .. rsal Health Services Under StockCall's Microscope
[ Fri, Apr 12th 2013 ] - Market Wire
Today's Technical View on Sequenom, Peregrine Pharma, Inovio Pharma, and Onyx Pharma
[ Fri, Apr 12th 2013 ] - Market Wire
ProMetic Begins Trading on OTCQX(R)
Thu, April 11, 2013
[ Thu, Apr 11th 2013 ] - Market Wire
Regeneron to Report First Quarter 2013 Financial .. d Host Conference Call and Webcast on May 3, 2013
[ Thu, Apr 11th 2013 ] - Market Wire
MiMedx to Present at Regen Med Investor Day 2013
[ Thu, Apr 11th 2013 ] - Market Wire
Sunshine Heart, Inc. Prices $13.1 Million Public Offering of Common Shares
[ Thu, Apr 11th 2013 ] - Market Wire
Biologix Hair Inc. Announces Upward Revisions to Initially Reported Clinician Licensing Numbers
[ Thu, Apr 11th 2013 ] - Market Wire
Sarepta Therapeutics and University of Western Au .. rldwide Licensing Agreement for Exon-Skipping Pro
[ Thu, Apr 11th 2013 ] - Market Wire
BIOLASE Engages Porter, LeVay &;; Rose, Inc. for Investor Relations
[ Thu, Apr 11th 2013 ] - Market Wire
15 PM EDT
[ Thu, Apr 11th 2013 ] - Market Wire
AtheroNova Adds New Medical Advisor
[ Thu, Apr 11th 2013 ] - Market Wire
Boston Therapeutics Requests an IND Meeting With .. uce Postprandial Hyperglycemia in Type 2 Diabetes
[ Thu, Apr 11th 2013 ] - Market Wire
Pharmacyclics Triggers Fourth Milestone Payment f .. t of 5th Patient in Frontline Phase III CLL Study
Wed, April 10, 2013
[ Wed, Apr 10th 2013 ] - Market Wire
Sangamo BioSciences Announces Presentation At Regen Med Investor Day
[ Wed, Apr 10th 2013 ] - Market Wire
MEI Pharma's Mitochondrial Inhibitor Drug Candida .. ys Tumor Growth In Recurrent Ovarian Cancer Model
[ Wed, Apr 10th 2013 ] - Market Wire
Sirona Biochem Renews Corporate Development Contract with Ray Matthews and Associates
[ Wed, Apr 10th 2013 ] - Market Wire
Rotech Receives Approval of First Day Motions; .. 59; Approvals Ensure Operations Continue Normally
[ Wed, Apr 10th 2013 ] - Market Wire
Data Presented at AACR Annual Meeting Support Tar .. hanism and Potential of Peregrine's Bavituximab i
[ Wed, Apr 10th 2013 ] - Market Wire
USANA Receives More Than 20 Awards During First Quarter
[ Wed, Apr 10th 2013 ] - Market Wire
Extendicare Announces 2013 First Quarter Financia .. e, Conference Call and Annual Meeting Information
[ Wed, Apr 10th 2013 ] - Market Wire
Stocks Move Higher as Apple May Release New iPhone in Up to Three Different Sizes
[ Wed, Apr 10th 2013 ] - Market Wire
Aeterna Zentaris and Ergomed Sign Co-Development .. ring Agreement for AEZS-108 in Endometrial Cancer
[ Wed, Apr 10th 2013 ] - Market Wire
Omeros Announces that GPR17 Antagonists Improve Function in Model of Multiple Sclerosis
Tue, April 9, 2013
[ Tue, Apr 09th 2013 ] - Market Wire
Canada's Largest Automated Hematology System is Now Live at CML HealthCare Inc.
[ Tue, Apr 09th 2013 ] - Market Wire
Stem Cell Therapeutics Completes Trillium Merger and Issues Stock Options
[ Tue, Apr 09th 2013 ] - Market Wire
Quest Diagnostics Completes Sale of HemoCue Business to Radiometer Medical ApS
[ Tue, Apr 09th 2013 ] - Market Wire
POZEN to Host Analyst and Investor Update Webcast
[ Tue, Apr 09th 2013 ] - Market Wire
Critical Outcome Technologies Inc. Provides Important Update on AML Program
[ Tue, Apr 09th 2013 ] - Market Wire
CardioGuide System Enables Real-Time Navigation o .. t Ventricular Leads During Medtronic CRT Implants
[ Tue, Apr 09th 2013 ] - Market Wire
DiagnoCure's adoption of an advance notice policy
[ Tue, Apr 09th 2013 ] - Market Wire
Theratechnologies Board of Directors Appoints Former Merck Canada President
[ Tue, Apr 09th 2013 ] - Market Wire
30 a.m. ET
[ Tue, Apr 09th 2013 ] - Market Wire
Research shows that superbugs are killed by ACTICOATa" silver-coated antimicrobial dressings
Mon, April 8, 2013
[ Mon, Apr 08th 2013 ] - Market Wire
OriGene to Acquire SDIX's Life Science Business Assets
[ Mon, Apr 08th 2013 ] - Market Wire
DiaMedica Receives Phase I/II Clinical Trial Regu .. for DM-199 as a Potential Treatment for Diabetes
[ Mon, Apr 08th 2013 ] - Market Wire
CryoLife To Host Central Venous Pathology Summit
[ Mon, Apr 08th 2013 ] - Market Wire
French National Television Newscast Highlights En .. ring Hansen Medical's Magellan(TM) Robotic System
[ Mon, Apr 08th 2013 ] - Market Wire
Boston Therapeutics Featured in Four Publications
[ Mon, Apr 08th 2013 ] - Market Wire
Merz Pharma Group Withdraws Proposal to Acquire Obagi Medical Products
[ Mon, Apr 08th 2013 ] - Market Wire
Theratechnologies Announces Termination of Agreement With Ferrer
[ Mon, Apr 08th 2013 ] - Market Wire
NewLink Genetics Presents Preclinical Data on New .. ay Inhibitor, NLG919, at AACR 2013 Annual Meeting
[ Mon, Apr 08th 2013 ] - Market Wire
Pharmacyclics Announces Third Breakthrough Therap .. utinib from the U.S. Food and Drug Administration
[ Mon, Apr 08th 2013 ] - Market Wire
SciClone Appoints PricewaterhouseCoopers LLP as Its Independent Registered Public Accounting Firm
Sat, April 6, 2013
[ Sat, Apr 06th 2013 ] - Market Wire
GlaxoSmithKline and Liberty Property Trust/Synter .. k Environment with the Opening of Five Crescent D
Fri, April 5, 2013
[ Fri, Apr 05th 2013 ] - Market Wire
Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
[ Fri, Apr 05th 2013 ] - Market Wire
The Law Firm of Levi &;; Korsinsky Noti .. n Their Investment in Incyte Corporation of Class
[ Fri, Apr 05th 2013 ] - Market Wire
East Tennessee Children's Hospital Installs Masim .. for Improved Oversight of Postoperative Patients
[ Fri, Apr 05th 2013 ] - Market Wire
GlaxoSmithKline and Liberty Property Trust/Synter .. k Environment with the Opening of Five Crescent D
[ Fri, Apr 05th 2013 ] - Market Wire
Uroplasty Announces CEO Resignation
[ Fri, Apr 05th 2013 ] - Market Wire
Sarepta Therapeutics Announces Eteplirsen Demonst .. lking Test Through 74 Weeks in Phase IIb Study in
[ Fri, Apr 05th 2013 ] - Market Wire
Arena Pharmaceuticals Initiates Phase 1 Clinical Trial of APD334 for Autoimmune Diseases
[ Fri, Apr 05th 2013 ] - Market Wire
Trimel Pharmaceuticals Corporation Announces Upda .. Milestone Payment and Amendment to Loan Agreement
[ Fri, Apr 05th 2013 ] - Market Wire
MEI Pharma Announces $15.2 Million Registered Offering Of Common Stock
[ Fri, Apr 05th 2013 ] - Market Wire
EntreMed Announces Changes to Board of Directors and CEO Appointment
Thu, April 4, 2013
[ Thu, Apr 04th 2013 ] - Market Wire
Pharmagen Presents to North Carolina General Assembly at N.C. Bio's Legislative Breakfast
[ Thu, Apr 04th 2013 ] - Market Wire
Syneron lanza la tecnologa exclusiva Sublative para cicatrices de acn
[ Thu, Apr 04th 2013 ] - Market Wire
BIOLASE Joins OSAP in Fight for Safe and Infection-Free Oral Healthcare
[ Thu, Apr 04th 2013 ] - Market Wire
Turning Atlanta into America's Next Silicon Valley
[ Thu, Apr 04th 2013 ] - Market Wire
CryoLife Receives FDA Clearance For Next Generation HeRO Device
[ Thu, Apr 04th 2013 ] - Market Wire
Array BioPharma Announces Updates on ARRY-520 Cli .. l Data at the 2013 International Myeloma Workshop
[ Thu, Apr 04th 2013 ] - Market Wire
Life Technologies Launches Oncomine Bioinformatics Solutions for Cancer Researchers
[ Thu, Apr 04th 2013 ] - Market Wire
StockCall Early Morning Insight into Covidien, Be .. Co., Stryker, MAKO Surgical, and Align Technology
[ Thu, Apr 04th 2013 ] - Market Wire
CEL-SCI's Price Rebound Looks Strong
[ Thu, Apr 04th 2013 ] - Market Wire
VolitionRx Files Two Patent Applications
Wed, April 3, 2013
[ Wed, Apr 03rd 2013 ] - Market Wire
Dako to Offer New Antibody in U.S. to Diagnose Breast Cancer
[ Wed, Apr 03rd 2013 ] - Market Wire
Biologix Hair to Exhibit at the 11th Annual Anti- .. g Medicine World Congress, Grimaldi Forum, Monaco
[ Wed, Apr 03rd 2013 ] - Market Wire
Cynosure Announces Presentation of 16 Abstracts at 33rd ASLMS Annual Conference
[ Wed, Apr 03rd 2013 ] - Market Wire
DARA BioSciences Enters Into Distribution Agreeme .. mox(R) With Prime Therapeutics Specialty Pharmacy
[ Wed, Apr 03rd 2013 ] - Market Wire
Renegotiated Lease to Generate Substantial Annual Savings
[ Wed, Apr 03rd 2013 ] - Market Wire
Isis Initiates Phase 1 Study of ISIS-APOA Rx to Treat Atherosclerosis
[ Wed, Apr 03rd 2013 ] - Market Wire
Actavis Confirms Court Issues TRO Related to Generic Pulmicort RESPULES Distribution
[ Wed, Apr 03rd 2013 ] - Market Wire
Simcere Pharmaceutical Group Announces its Special Committee's Engagement of Financial Advisor
[ Wed, Apr 03rd 2013 ] - Market Wire
Perceptive Informatics Improves Clinical Trial Management With New Release Of IMPACT CTMS Solution
Tue, April 2, 2013
[ Tue, Apr 02nd 2013 ] - Market Wire
SuperSonic Imagine Announces a Significant Financ .. Raised -- FSI Subscribes to Half the Round Along
[ Tue, Apr 02nd 2013 ] - Market Wire
Gatorz Inc. Appoints New Chief Executive Officer
[ Tue, Apr 02nd 2013 ] - Market Wire
Centene Corporation Completes Acquisition Of Specialty Pharmacy Leader AcariaHealth
[ Tue, Apr 02nd 2013 ] - Market Wire
Bioheart Completes FDA Registration for Tissue Bank Establishment
[ Tue, Apr 02nd 2013 ] - Market Wire
LCA-Vision Reports First Quarter 2013 Procedure Volume
[ Tue, Apr 02nd 2013 ] - Market Wire
China Cord Blood Corporation Received AABB Accreditation
[ Tue, Apr 02nd 2013 ] - Market Wire
IRIDEX Announces Global Distribution and Supply Agreement with Peregrine Surgical, Ltd.
[ Tue, Apr 02nd 2013 ] - Market Wire
Sinovac Schedules Conference Call and Webcast for .. Quarter and Full Year Unaudited Financial Results
[ Tue, Apr 02nd 2013 ] - Market Wire
Ampio Receives FDA Clearance to Initiate Clinical .. eatment of Osteoarthritis of the Knee: Patient Tr
Mon, April 1, 2013
[ Mon, Apr 01st 2013 ] - Market Wire
Vasomedical Announces Share Repurchase Program of up to $1.5 Million in Common Stock
[ Mon, Apr 01st 2013 ] - Market Wire
Rosetta Genomics Announces Acceptance for Publica .. roRNA Diagnostic Manuscript by Molecular Oncology
[ Mon, Apr 01st 2013 ] - Market Wire
Today's Technical View on AstraZeneca, GlaxoSmithKline, PDL BioPharma, and Herbalife
[ Mon, Apr 01st 2013 ] - Market Wire
Isis Publishes Data Demonstrating Antisense Targe .. Significantly Reduces ApoC-III and Triglycerides
[ Mon, Apr 01st 2013 ] - Market Wire
Adherex Provides Corporate Update and Fiscal Year Ended December 31, 2012 Financial Results
[ Mon, Apr 01st 2013 ] - Market Wire
Implant Sciences Wins Contract for Seven Quantum Sniffers to Africa
[ Mon, Apr 01st 2013 ] - Market Wire
Threshold Pharmaceuticals Announces Presentation .. l Future Leaders in the Biotech Industry Conferen
[ Mon, Apr 01st 2013 ] - Market Wire
SciClone Pharmaceuticals to Report 2012 Financial Results and 2013 Outlook on April 1st
[ Mon, Apr 01st 2013 ] - Market Wire
Life Technologies Offers New Rapid DNA Platform
Fri, March 29, 2013
[ Fri, Mar 29th 2013 ] - Market Wire
Faruqi amp;; Faruqi, LLP Encourages Invest .. xcess of $100,000 Investing In Incyte Corporation
[ Fri, Mar 29th 2013 ] - Market Wire
Faruqi amp;; Faruqi, LLP Encourages Invest .. cess Of $100,000 Investing In Impax Laboratories,
[ Fri, Mar 29th 2013 ] - Market Wire
Galectin Therapeutics Reports Full Year and Fourth Quarter 2012 Financial Results
[ Fri, Mar 29th 2013 ] - Market Wire
Merus Announces Annual General Meeting Results
[ Fri, Mar 29th 2013 ] - Market Wire
Discovery Labs Announces Newly-Released SURFAXIN (lucinactant) Publications
[ Fri, Mar 29th 2013 ] - Market Wire
Omeros to Present at the 2013 Future Leaders in the Biotech Industry Conference
Thu, March 28, 2013
[ Thu, Mar 28th 2013 ] - Market Wire
SpectraScience Schedules Business Update Conference Call
[ Thu, Mar 28th 2013 ] - Market Wire
Basketball Legend Lisa Leslie Teams Up with Alleg .. milies Enjoy Outdoor Workouts This Allergy Season
[ Thu, Mar 28th 2013 ] - Market Wire
Dr. Emad Rizk Joins Accuray Board of Directors
[ Thu, Mar 28th 2013 ] - Market Wire
MGC Diagnostics Corporation Announces Special Cas .. ividend and Extension of Stock Repurchase Program
[ Thu, Mar 28th 2013 ] - Market Wire
Deep Brain Stimulation (DBS) with ClearPoint Neur .. vention System Featured on Fox News Health Online
[ Thu, Mar 28th 2013 ] - Market Wire
Horizon Pharma to Present at the 20th Annual Future Leaders in the Biotech Industry Conference
[ Thu, Mar 28th 2013 ] - Market Wire
Omeros Announces Toxicology Data that Support Advancing MASP-2 Inhibitor into Clinical Trials
[ Thu, Mar 28th 2013 ] - Market Wire
Stem Cell Therapeutics Provides Corporate Update on Acquisitions and Financing
[ Thu, Mar 28th 2013 ] - Market Wire
Oncolytics Biotech Inc. Meets Primary Overall Sta .. se 2 Study of REOLYSIN in Squamous Cell Lung Canc
Wed, March 27, 2013
[ Wed, Mar 27th 2013 ] - Market Wire
Anthera Initiates CHABLIS-SC1 Phase 3 Clinical Study in Lupus with Blisibimod
[ Wed, Mar 27th 2013 ] - Market Wire
Prana Announces Successful A$7 Million Capital Raising
[ Wed, Mar 27th 2013 ] - Market Wire
Med BioGene Announces New Marketing Name for Lung Cancer Test
[ Wed, Mar 27th 2013 ] - Market Wire
NuVasive(R) to Exhibit at ISASS 2013
[ Wed, Mar 27th 2013 ] - Market Wire
International Stem Cell Corporation Announces Fou .. 12 Financial Results and Provides Business Update
[ Wed, Mar 27th 2013 ] - Market Wire
Insmed to Present at Future Leaders in the Biotech Industry Conference
[ Wed, Mar 27th 2013 ] - Market Wire
Neurocrine Biosciences Announces the Start of Phase IIb Study of Elagolix in Uterine Fibroids
[ Wed, Mar 27th 2013 ] - Market Wire
Bioheart's Appeals to the FDA for Compassionate Use Designation to Save Lives
[ Wed, Mar 27th 2013 ] - Market Wire
To Accelerate Commercialization of PAZ320 &
Tue, March 26, 2013
[ Tue, Mar 26th 2013 ] - Market Wire
Galapagos to start Phase 2a study with GLPG0974 in IBD patients
[ Tue, Mar 26th 2013 ] - Market Wire
Patient Home Monitoring (PHM) Releases an Updated .. eetings to Introduce Robert Kusher, Its CEO to th
[ Tue, Mar 26th 2013 ] - Market Wire
Cardiome Announces Changes to Senior Management Team
[ Tue, Mar 26th 2013 ] - Market Wire
ProMetic Reports its Fourth Quarter and Financial Year 2012 Results
[ Tue, Mar 26th 2013 ] - Market Wire
Anthera Pharmaceuticals Reports 2012 Fourth Quarter And Fiscal Year Financial Results
[ Tue, Mar 26th 2013 ] - Market Wire
Venaxis Advances Pivotal U.S. Study and Accelerat .. velopment for APPY1 Blood-based Appendicitis Test
[ Tue, Mar 26th 2013 ] - Market Wire
Alexza Reports 2012 Fourth Quarter and Full Year Financial Results
[ Tue, Mar 26th 2013 ] - Market Wire
Star Scientific Responds to Plaintiff's Purported Class Action Lawsuit
[ Tue, Mar 26th 2013 ] - Market Wire
Harwood Feffer LLP Announces Investigation of Star Scientific, Inc.

POZEN to Host Analyst and Investor Update Webcast


//health-fitness.news-articles.net/content/2013/ .. to-host-analyst-and-investor-update-webcast.html
Published in Health and Fitness on by Market Wire   Print publication without navigation


April 09, 2013 16:05 ET

POZEN to Host Analyst and Investor Update Webcast

CHAPEL HILL, NC--(Marketwired - Apr 9, 2013) -  POZEN Inc. (NASDAQ: [ POZN ]), a pharmaceutical company committed to transforming medicine that transforms lives, today announced that it will hold an Analyst and Investor Update webcast Thursday, April 18, 2013 from 10:00 a.m. - 11:30 a.m. (EDT). During the webcast, management will provide an update for POZEN's PA program and two outside experts will discuss thoughts on the use of aspirin in the cardiovascular space and the reimbursement landscape. The live webcast and replay will be available at [ www.pozen.com ].

About POZEN

POZEN Inc. is a small pharmaceutical company that specializes in developing novel therapeutics for unmet medical needs and licensing those products to other pharmaceutical companies for commercialization. By utilizing a unique in-source model and focusing on integrated therapies, POZEN has successfully developed and obtained FDA approval of two self-invented products in two years. Funded by these milestones/royalty streams, POZEN is creating a portfolio of cost-effective, evidence-based integrated aspirin therapies designed to enable the full power of aspirin by reducing its GI damage.

POZEN is currently seeking strategic partners to help maximize the opportunities for its portfolio assets.

The Company's common stock is traded under the symbol "POZN" on The NASDAQ Global Market. For more detailed company information, including copies of this and other press releases, please visit [ www.pozen.com ].



Publication Contributing Sources